Circularis Overview

  • Year Founded
  • 2014

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 9

Employees

  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $18.6M

  • Investors
  • 1

Circularis General Information

Description

Operator of a biotech company intended to regulate gene expression. The company offers gene therapy, biomanufacturing, and synthetic biology, improving the targeting of gene therapy and optimizing expression in poorly studied organisms, enabling medical practitioners to increase biotherapeutic production.

Contact Information

Formerly Known As
DtoR
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • 2945 Webster Street
  • Oakland, CA 94609
  • United States
Primary Industry
Discovery Tools (Healthcare)
Acquirer
Corporate Office
  • 2945 Webster Street
  • Oakland, CA 94609
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Circularis Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Merger/Acquisition 03-Oct-2022 $18.6M Completed Out of Business
5. Accelerator/Incubator Completed Generating Revenue
4. Later Stage VC 01-Jan-2022 Completed Generating Revenue
3. Seed Round 09-Apr-2020 Completed Generating Revenue
2. Accelerator/Incubator 04-Sep-2015 $250K Completed Startup
1. University Spin-Out 01-Jan-2014 Completed Startup
To view Circularis’s complete valuation and funding history, request access »

Circularis Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Seed 2
Seed
To view Circularis’s complete cap table history, request access »

Circularis Patents

Circularis Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-4433592-A1 Compositions and methods for production of circular nucleic acid molecules Inactive 18-Nov-2021
US-20250011767-A1 Compositions and methods for production of circular nucleic acid molecules Inactive 18-Nov-2021
WO-2023091704-A1 Compositions and methods for production of circular nucleic acid molecules Inactive 18-Nov-2021 C12N15/11

Circularis Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Circularis Former Investors (8)

Investor Name Investor Type Holding Investor Since Participating Rounds
Alix Ventures Venture Capital Minority
Bioverge Venture Capital Minority
California Life Sciences Accelerator/Incubator
Cantos Ventures Venture Capital Minority
Angel (individual) Minority
You’re viewing 5 of 8 investors. Get the full list »

Circularis FAQs

  • When was Circularis founded?

    Circularis was founded in 2014.

  • Where is Circularis headquartered?

    Circularis is headquartered in Oakland, CA.

  • What is the size of Circularis?

    Circularis has 9 total employees.

  • What industry is Circularis in?

    Circularis’s primary industry is Discovery Tools (Healthcare).

  • Is Circularis a private or public company?

    Circularis is a Private company.

  • What is the current valuation of Circularis?

    The current valuation of Circularis is .

  • What is Circularis’s current revenue?

    The current revenue for Circularis is .

  • How much funding has Circularis raised over time?

    Circularis has raised $2.55M.

  • Who are Circularis’s investors?

    Alix Ventures, Bioverge, California Life Sciences, Cantos Ventures, and are 5 of 8 investors who have invested in Circularis.

  • When was Circularis acquired?

    Circularis was acquired on 03-Oct-2022.

  • Who acquired Circularis?

    Circularis was acquired by Ginkgo Bioworks.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process